Cipla’s arm acquires additional 15.10% stake in Cipla Maroc SA

28 Nov 2023 Evaluate

Cipla’s wholly owned subsidiary -- Cipla (EU) has completed acquisition of additional 15.10% in the Cipla Maroc SA, Morocco, (JV Co.), from The Pharmaceutical Institute (PHI) for a consideration of Moroccan Dirham 81.1 million on November 24, 2023. 

Accordingly, Cipla EU will now hold 75.10% stake in the JV Co. and balance 24.90% stake will be held by Societe Marocaine De Cooperation Pharmaceutique (CooperPharma).

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1369.55 -8.30 (-0.60%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×